首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1490007

獸醫腫瘤學市場，按動物類型、按治療類型、按劑型、按應用、按配銷通路、按地區

Veterinary Oncology Market, By Animal Type, By Therapy Type, By Mode of Administration, By Application, By Distribution Channel, By Geography

出版日期: 2024年05月23日 | 出版商:

Coherent Market Insights | 英文 225 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024年全球獸醫腫瘤市場價值將達7.249億美元，預計到2031年將達到15.637億美元，2024年至2031年年複合成長率為11.6%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	7.249 億美元
實際資料	2019-2023	預測期	2024-2031
2024-2031 年預測期間的年複合成長率：	11.60%	2031 年金額預測	15.637 億美元

圖：2024 年按地區分類的獸醫腫瘤市場佔有率 (%)

由於動物保健支出的增加和寵物擁有量的增加，獸醫腫瘤學市場正在顯著成長。人類與動物關係的加深以及對伴侶動物癌症認知的不斷提高，推動了對獸醫腫瘤學先進診斷方法和治療程序的需求。此外，狗和貓的淋巴瘤、乳腺癌、口腔黑色素瘤和肥大細胞瘤等癌症的發生率不斷增加，增加了對有效治療方案和早期檢測的需求。越來越多的獸醫腫瘤學家和腫瘤學專家以及對創新製劑開發的持續研究也進一步推動了全球市場的擴張。然而，與癌症治療和診斷程序相關的高成本仍然是一個重大挑戰。

市場動態：

全球獸醫腫瘤學市場的成長是由伴同性動物癌症盛行率上升、寵物保險採用率上升、獸醫醫療保健成本上升和技術進步所推動的。統計顯示，10歲以上的狗狗有超過50%會罹患癌症，而淋巴瘤是狗狗最常見的血癌。快速的都市化、核心家庭和日益增加的孤獨感正在推動全世界養寵物的人數增加。這使得寵物飼主更加關注寵物的健康，並花錢購買高階治療。各種組織為與獸醫腫瘤學相關的臨床試驗和研究活動提供財務支持，這在市場成長中發揮重要作用。然而，與腫瘤藥物、診斷測試和手術相關的高昂成本以及新興國家缺乏認知預計將阻礙預測期內的市場擴張。透過社群媒體宣傳活動和會議不斷努力傳播人們對寵物癌症的認知，預計將為市場主要企業創造大量有利可圖的機會。

本研究的主要特點

該報告對全球獸醫腫瘤市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球獸醫腫瘤學市場的主要企業。
主要公司包括 Zoetis Inc.、Elanco、AB Science、Boehringer Ingelheim International GmbH、Zenoaq、VetDC、Morphogenesis, Inc.、Karyopharm Therapeutics, Inc.、Regeneus Ltd.、AdvaVet, Inc.、Rhizen Pharmaceutical SA.、PetCure Oncology 、VarVet Medical Systems、Accuray Incorporated、One Health 與Regeneus Ltd.
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球獸醫腫瘤學市場迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球獸醫腫瘤學市場的各種策略矩陣來促進決策。

公司簡介
- Zoetis Inc.
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA.
- PetCure Oncology
- Varian Medical Systems
- Accuray Incorporated
- One Health
- Regeneus Ltd.

第12章分析師建議

命運之輪
分析師觀點
Coherent Opportunity Map

第13章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI2995

Global veterinary oncology market is estimated to be valued at USD 724.9 Mn in 2024 and is expected to reach USD 1,563.7 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 724.9 Mn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	11.60%	2031 Value Projection:	US$ 1,563.7 Mn

Figure. Veterinary Oncology Market Share (%), By Region, 2024

The veterinary oncology market is experiencing significant growth due to rising animal healthcare expenditure and increasing pet ownership. Growing human-animal bonds and rising awareness about cancer in companion animals are propelling demand for advanced diagnostic methods and therapeutic procedures for veterinary oncology. Moreover, increasing incidence of cancers such as lymphoma, mammary tumor, oral melanoma, and mast cell tumors in dogs and cats is driving the need for effective treatment options and early detection. Growing number of veterinary oncologists and oncology specialists along with ongoing research for developing innovative drug formulations are further supporting market expansion on a global level. However, high costs associated with cancer therapies and diagnostic procedures remain a major challenge.

Market Dynamics:

The global veterinary oncology market growth is driven by rising incidence of cancer in companion animals, increase in pet insurance purchases, growing animal health expenditure, and technological advancements. According to statistics, over 50% of dogs over the age of 10 will develop cancer and lymphoma is the most common blood cancer in dogs. Rapid urbanization accompanied with rising nuclear families and increasing loneliness levels have boosted pet adoption rates globally. This has led to pet owners becoming more aware regarding the health of their pets and willing to spend more on premium treatments. Various organizations are financially supporting clinical trials and research activities related to veterinary oncology which is playing a significant role in market growth. However, high costs associated with oncology medications, diagnostic tests, surgeries, and lack of awareness in developing nations are anticipated to hamper the market expansion during the forecast period. Ongoing initiatives to spread awareness regarding cancer in pets through social media campaigns and conferences are expected to bring numerous lucrative opportunities for key players in the market.

Key Features of the Study:

This report provides an in-depth analysis of the global veterinary oncology market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global veterinary oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this includes Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., Rhizen Pharmaceutical SA., PetCure Oncology, Varian Medical Systems, Accuray Incorporated, One Health, and Regeneus Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global veterinary oncology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary oncology market

Detailed Segmentation-

By Animal Type:
- Companion Animal
- Equine
- Canine
- Feline
- Livestock Animal
By Therapy Type:
- Chemotherapy
- Combination Therapy
- Immunotherapy
- Targeted Therapy
By Mode of Administration:
- Oral
- Intravenous
By Application:
- Canine Lymphoma
- Osteosarcoma (OSA)
- Mast Cell Cancer
- Melanoma
- Others
By Distribution Channel:
- Hospital Pharmacies
- Government Agencies
- Retail Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Zoetis Inc.
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA.
- PetCure Oncology
- Varian Medical Systems
- Accuray Incorporated
- One Health
- Regeneus Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Animal Type
- Market Snapshot, By Therapy Type
- Market Snapshot, By Mode of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Epidemiology
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Veterinary Oncology Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Veterinary Oncology Market, By Animal Type, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Companion Animal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Equine
Canine
Feline
Livestock Animal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Veterinary Oncology Market, By Therapy Type, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Combination Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Targeted Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Veterinary Oncology Market, By Mode of Administration, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Veterinary Oncology Market, By Application, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Canine Lymphoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Osteosarcoma (OSA)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Mast Cell Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Melanoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Veterinary Oncology Market, By Distribution Channel, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Government Agencies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

10. Global Veterinary Oncology Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.S.
  - Canada
  - Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
  - Europe
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
  - Asia Pacific
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
  - Middle East
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
  - North Africa
  - Central Africa
  - South Africa

11. Competitive Landscape

Company Profiles
- Zoetis Inc.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA.
- PetCure Oncology
- Varian Medical Systems
- Accuray Incorporated
- One Health
- Regeneus Ltd.